Zions Bancorporation, N.A. Vertex Pharmaceuticals Inc Transaction History

Zions Bancorporation, N.A.

$1.36 Billion
Q3 2024

A detailed history of Zions Bancorporation, N.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 171 shares of VRTX stock, worth $79,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares

171

Previous 216 20.83%

Holding current value

$79,439

Previous $101,000 21.78%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$460.0 - $505.78 $20,700 - $22,760	-45 Reduced 20.83%	171 $79,000
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $32,603 - $40,298	-83 Reduced 27.76%	216 $101,000
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $288,236 - $315,378	-707 Reduced 70.28%	299 $124,000
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $49,049 - $58,727	-143 Reduced 12.45%	1,006 $409,000
Q3 2023 Nov 07, 2023	SELL	$338.18 - $362.46 $8,116 - $8,699	-24 Reduced 2.05%	1,149 $399,000
Q2 2023 Jul 28, 2023	SELL	$314.42 - $351.91 $3,458 - $3,871	-11 Reduced 0.93%	1,173 $412,000
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $104,228 - $118,900	368 Added 45.1%	1,184 $373,000
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $18,574 - $20,896	65 Added 8.66%	816 $235,000
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $547 - $611	-2 Reduced 0.27%	751 $217,000
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $8,693 - $10,824	37 Added 5.17%	753 $212,000
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $92,996 - $109,607	420 Added 141.89%	716 $187,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $9,735 - $12,289	-55 Reduced 15.67%	296 $65,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $27,752 - $31,057	-153 Reduced 30.36%	351 $64,000
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $33,373 - $39,355	178 Added 54.6%	504 $102,000
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $4,554 - $5,308	-22 Reduced 6.32%	326 $70,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $2,070 - $2,760	-10 Reduced 2.79%	348 $82,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $15,594 - $18,489	61 Added 20.54%	358 $97,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $3,382 - $4,437	-15 Reduced 4.81%	297 $86,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $15,382 - $19,081	-77 Reduced 19.79%	312 $74,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $3,000 - $4,030	-18 Reduced 4.42%	389 $85,000
Q2 2019 Jul 09, 2019	SELL	$164.61 - $190.37 $7,407 - $8,566	-45 Reduced 9.96%	407 $75,000
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $654 - $778	-4 Reduced 0.88%	452 $83,000
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $69,270 - $87,647	456 New	456 $76,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Vertex Pharmaceuticals Inc Transaction History